Other Non-Current Liabilities
West Pharmaceutical Services Other Non-Current Liabilities increased by 16.5% to $87.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $65.70M to $87.60M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 18.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.60M | $27.80M | $38.20M | $38.20M | $34.80M | $33.90M | $51.60M | $55.80M | $55.10M | $55.10M | $58.50M | $57.90M | $63.10M | $66.80M | $62.20M | $65.70M | $70.40M | $75.30M | $75.20M | $87.60M |
| QoQ Change | — | -6.1% | +37.4% | +0.0% | -8.9% | -2.6% | +52.2% | +8.1% | -1.3% | +0.0% | +6.2% | -1.0% | +9.0% | +5.9% | -6.9% | +5.6% | +7.2% | +7.0% | -0.1% | +16.5% |
| YoY Change | — | — | — | — | +17.6% | +21.9% | +35.1% | +46.1% | +58.3% | +62.5% | +13.4% | +3.8% | +14.5% | +21.2% | +6.3% | +13.5% | +11.6% | +12.7% | +20.9% | +33.3% |
Product Breakdown
| Segment | Q4 '21 |
|---|---|
| Smart Dose | $3.00M |
| Total | $38.20M |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other non-current liabilities?
- West Pharmaceutical Services (WST) reported other non-current liabilities of $87.60M in Q1 2026.
- How has West Pharmaceutical Services's other non-current liabilities changed year-over-year?
- West Pharmaceutical Services's other non-current liabilities increased by 33.3% year-over-year, from $65.70M to $87.60M.
- What is the long-term trend for West Pharmaceutical Services's other non-current liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's other non-current liabilities has grown at a 18.8% compound annual growth rate (CAGR), from $31.80M to $75.20M.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.